Phase I Study of Pomalidomide, Dexamethasone and Rituximab (PDR) in Relapsed or Refractory Waldenstrom's Macroglobulinemia.
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2016
At a glance
- Drugs Pomalidomide (Primary) ; Dexamethasone; Rituximab
- Indications Waldenstrom's macroglobulinaemia
- Focus Adverse reactions
- 13 Jun 2016 Status changed from active, no longer recruiting to discontinued.
- 14 Aug 2015 Planned End Date changed from 1 May 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 14 Aug 2015 Planned primary completion date changed from 1 May 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.